Pharming Group (OTCMKTS:PHGUF – Get Free Report) hit a new 52-week low during mid-day trading on Monday . The company traded as low as $0.95 and last traded at $0.95, with a volume of 0 shares changing hands. The stock had previously closed at $0.95.
Pharming Group Price Performance
The company has a debt-to-equity ratio of 0.76, a current ratio of 4.06 and a quick ratio of 3.33. The business has a 50 day simple moving average of $1.16 and a 200 day simple moving average of $1.16. The company has a market capitalization of $619.79 million, a price-to-earnings ratio of -95.00 and a beta of 1.07.
About Pharming Group
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks.
Further Reading
- Five stocks we like better than Pharming Group
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- Energy and Oil Stocks Explained
- Merger or Not, Albertson’s Companies is a Good Buy
- Overbought Stocks Explained: Should You Trade Them?
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
